Clinical Trials
- Asthma
EPIPHANY study for people with moderate to severe asthma
- Asthma
Safety Study of Tezepelumab in Adult and Adolescent Participants With Severe Asthma (PASSAGE)
- Ages18 years - 130 years
- GenderBoth
- Asthma, Men's Health, Women's Health
Observational Study of Characteristics, Treatment and Outcomes With Severe Asthma in the United States (CHRONICLE)
- Ages18 years and older
- GenderBoth
- Phase 1 Cancers
Phase Ia, First in Human Open Label Dose Escalation Trial Evaluating Intravenous BI 1703880 in Combination With Intravenous Ezabenlimab for Treatment of Advanced Solid Tumours